On December 9th, JXR (01951) spent 9.2077 million Hong Kong dollars to repurchase 3.802 million shares.

21:03 09/12/2025

Jinxin Reproduction (01951) announced that on December 9, 2025, the company spent 9.2077 million Hong Kong dollars to repurchase 3.802 million shares, with a repurchase price of 2.4-2.5 Hong Kong dollars per share.

JXR (01951) announced on December 9, 2025, that the company will spend HKD 9.2077 million to repurchase 3.802 million shares, with a repurchase price of HKD 2.4-2.5 per share.

HK Stock Market Move | XUANZHUBIO-B(02575) surged by over 5% approaching previous high. Its innovative drug Xuanyue Ning was included in the national basic medical insurance drug list for the first time.

CMSC International: Expects moderate economic growth in the United States next year, with Hong Kong stocks poised to shift towards profit growth as the main driver.

Zhongtai: The aviation supply and demand structure is expected to continue to improve in 2026, with a strong increase in ticket prices compared to the previous year.

CMSC International: Expects moderate economic growth in the United States next year, with Hong Kong stocks poised to shift towards profit growth as the main driver.

Zhongtai: The aviation supply and demand structure is expected to continue to improve in 2026, with a strong increase in ticket prices compared to the previous year.